Member access

4-Traders Homepage  >  Shares  >  Swiss Exchange  >  Roche Holding Ltd.    ROG   CH0012032048

ROCHE HOLDING LTD. (ROG)

278
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Swiss Exchange
05/18/2015 05/19/2015 05/20/2015 05/21/2015 05/22/2015 Date
277(c) 278.3(c) 277.7(c) 279.2(c) 277.9(c) Last
1 477 174 1 394 764 998 186 1 203 678 1 020 539 Volume
+1.24% +0.47% -0.22% +0.54% -0.47% Change
More quotes
Financials ( CHF)
Sales 2015 48 111 M
EBIT 2015 17 098 M
Net income 2015 11 294 M
Debt 2015 9 484 M
Yield 2015 2,99%
Sales 2016 50 284 M
EBIT 2016 18 287 M
Net income 2016 12 328 M
Debt 2016 5 260 M
Yield 2016 3,19%
PER 2015 20,61
PER 2016 18,85
EV / Sales 2015 5,16x
EV / Sales 2016 4,86x
Capitalization 238 962 M
More Financials
Company
Roche Holding AG operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics.It operates business through two divisons: Pharmaceuticals and Diagnostics.The Pharmaceuticals divison comprises the two business segments Roche Pharmaceuticals and Chugai,... 
Sector
Pharmaceuticals
Calendar
05/27 | 09:00amPresentation
More about the company
Surperformance© ratings of Roche Holding Ltd.
Trading Rating : Investor Rating :
More Ratings
Latest news on ROCHE HOLDING LTD.
05/15DJEUROPE MARKETS : European Stocks Erase Draghi-inspired Gains After Weak U.S. Dat..
05/15DJEUROPE MARKETS : European Stocks Build On Draghi-inspired Gains
05/15DJEUROPE MARKETS : European Stocks Build On Draghi-inspired Gains
05/15DJEUROPE MARKETS : European Stocks Build On Draghi-inspired Gains
05/13DJPharma Industry Needs Billions of Dollars for Antibiotics Research
05/13 ROCHE : Genentech :’s Investigational Immunotherapy MPDL3280A Doubled the ..
05/13 ROCHE : Genentech :’s Investigational Medicine Alectinib Shrank Tumors in ..
05/11 ROCHE : Pivotal Data for Genentech Medicines in Lung and Blood Cancers to Be Pre..
More news
Sector news : Pharmaceuticals - NEC
05/23 GERMANY'S MERCK EXPECTS DRUG DIVISIO : Euro am Sonntag
05/22DJAmgen Ends Psoriasis-Drug Partnership With AstraZeneca -- Update
05/22 AMGEN : ends work on experimental psoriasis drug
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
05/23 UPCOMING EVENTS : A Dosing Decision For BioMarin, Plus Roche To Get Alzheimer's ..
05/20 Lpath's lead product candidate fails Phase 2 study; shares plunge 80%
05/20 Pfizer Trying To Overcome Patent Cliff
05/18 Ilumina files patent infringement suit against Roche subsidiary
05/17 The Weekender


Comments 
Advertisement
Chart ROCHE HOLDING LTD.
Duration : Period :
Roche Holding Ltd. Technical Analysis Chart | ROG | CH0012032048 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions